Hint mode is switched on Switch off

Nuvalent, ordinary share
NUVL, US6707031075

Add a stock to WL
Choose all Reset all
Nuvalent, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Nuvalent Inc is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
  • Issuer
  • Full borrower / issuer name
    Nuvalent Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    NUVL
  • Placement
    29.07.2021
  • Lock up period
    180
  • Number of papers
    9,150,000
  • Volume of raised funds
    155.55 mln USD
  • Placement share
    22.11%
  • Final placement price
    17 USD
  • Price change since placement date
    -100%
  • By capitalization
    703.57 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    NUVL
  • Placement
    01.11.2022
  • Lock up period
    180
  • Number of papers
    49,767,258
  • Volume of raised funds
    230 mln USD
  • Placement share
    13.8%
  • Final placement price
    33.5 USD
  • Price change since placement date
    270.03%
  • By capitalization
    1,667.2 mln USD

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
II q eng
III q eng
IV q eng
Show all Hide

Indicators

News

15/07/2026 Nuvalent: Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
16/06/2026 Nuvalent: Submission Of Matters To A Vote Of Security Holders
18/11/2025 Nuvalent, Inc. (NASDAQ: NUVL) Targets Advanced Cancer with Promising Drug Trials
18/11/2025 Nuvalent: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
24/06/2025 Nuvalent: Other Events
All organization news

Holders

Industry Leaders

Registration is required to get access.